The Academy submitted a letter to the Federal Drug Administration (FDA) requesting clarification on two critical issues included in the final OTC rule to ensure the final rule can be implemented in an expeditious manner.
Many state audiology licensing laws currently include a requirement that an individual receive medical clearance or sign a document waiving that requirement prior to receiving a hearing aid. The final rule is clear that these state provisions may continue to exist but only with regard to “prescription hearing aids.” However, current state laws or regulations do not differentiate between the two “types” of hearing aids and instead reference only “hearing aids.” Until state licensing rules are updated to differentiate requirements for OTC hearing aids versus prescription hearing aids, it will be important for the FDA to provide guidance to states in terms of how these provisions should be applied.
The final rule classifies all non-OTC hearing aids as “prescription.” We are concerned that some interests may equate “prescription” hearing aids as requiring a “prescription” from an individual with prescriptive authority as that term is currently used. Prescriptive authority is currently defined at the state level for mid-level practitioners such as nurse practitioners and physician assistants—and may differ depending on the type of practitioner. Audiologists are not included in this classification. The Academy asks the FDA to weigh in on the distinction between “prescription” hearing aids and “prescriptive” authority.
Related Posts
Biden-Harris Administration Releases Playbook to Address Social Determinants of Health (SDOH)
A growing body of evidence demonstrates the connection between health outcomes to income, education, nutrition, housing, environmental exposures, and other social circumstances. Similarly, studies have shown that interventions addressing SDOH can improve health outcomes and reduce health care costs. In response, the Biden-Harris Administration has released a playbook outlining new or strengthened initiatives that agencies…
Free Hearing Aids from Cochlear Implant Manufacturer May Violate Fraud and Abuse Laws
The U.S. Department of Health and Human Services Office of Inspector General (OIG) posted on October 25, 2023 Advisory Opinion No. 23-08, in which OIG rejected a proposed arrangement from a cochlear implant device manufacturer (the requestor) that would provide a free hearing aid to certain qualified patients who received a cochlear implant. OIG concluded the…
Representatives Bilirakis and Cartwright Introduce the Medicare Audiology Access Improvement Act of 2023 (H.R. 6445)
On November 17, 2023, Representative Gus Bilirakis (R-FL) and Matt Cartwright (D-PA) introduced the Medicare Audiology Access improvement Act (H.R. 6445). This legislation is also co-sponsored by Representatives Johnson (R-OH), Shakowsky (D-IL), Mace (R-SC), Blunt Rochester (D-DE), Fitzpatrick (R-PA), Trone (D-MD), Webster (R-FL), Cohen (D-TN), LaMalfa (R-CA), Grijalva (D-AZ), Foster (D-IL) and Pocan (D-WI). Senators Elizabeth…